Combined Effect of Bortezomib and Menadione Sodium Bisulfite on Proteasomes of Tumor Cells: The Dramatic Decrease of Bortezomib Toxicity in a Preclinical Trial

Proteasome inhibitors in cancer therapy: Treatment regimen and peripheral neuropathy as a side effect

(2017) Gulce Sari Kaplan et al.   FREE RADICAL BIOLOGY AND MEDICINE

Detection of active proteasome structures in brain extracts: proteasome features of August rat brain with violations in monoamine metabolism

(2017) Pavel A. Erokhov et al.   Oncotarget

Update on the optimal use of bortezomib in the treatment of multiple myeloma

(2017) Meera Mohan et al.   Cancer Management and Research

Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor

(2016) Tingyu Wu et al.   MOLECULAR CANCER THERAPEUTICS

Menadione induces the formation of reactive oxygen species and depletion of GSH-mediated apoptosis and inhibits the FAK-mediated cell invasion

(2014) Yun Jeong Kim et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Proteasome Functioning in Breast Cancer: Connection with Clinical-Pathological Factors

(2014) Elena E. Shashova et al.   PLoS One

Biodistribution and Efficacy Studies of the Proteasome Inhibitor BSc2118 in a Mouse Melanoma Model

(2014) Izabela Mlynarczuk-Bialy et al.   Translational Oncology

Expression of vascular endothelial growth factor and transcription factors HIF-1, NF-kB expression in squamous cell carcinoma of head and neck; association with proteasome and calpain activities

(2012) Liudmila V. Spirina et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Development of proteasome inhibitors as research tools and cancer drugs

(2012) Alfred L. Goldberg   JOURNAL OF CELL BIOLOGY

The Immunoproteasome as a Target in Hematologic Malignancies

(2012) Deborah J. Kuhn et al.   SEMINARS IN HEMATOLOGY

Sensitivity of acute myeloid leukemia Kasumi-1 cells to binase toxic action depends on the expression ofKITandАML1-ETOoncogenes

(2011) Vladimir A. Mitkevich et al.   CELL CYCLE

Pattern of MHC class I and immune proteasome expression in Walker 256 tumor during growth and regression in Brattleboro rats with the hereditary defect of arginine-vasopressin synthesis

(2011) Liudmila A. Zakharova et al.   CELLULAR IMMUNOLOGY

Changes in proteasome pool in human papillary thyroid carcinoma development

(2011) Natalia Sharova et al.   Open Life Sciences

Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, p21 and p27 levels

(2008) Daniele Baiz et al.   BIOCHIMIE